MONECO Advisors’s Traws Pharma TRAW Stock Holding History

MONECO Advisors’s Portfolio TRAW Stock Details TRAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-80	Closed	-$30K	–	235
2021 Q1	$30K	Sell	80 -80	-50%	-$30.2K	0.01%	218
2020 Q4	$41K	Buy	+160	New	+$18.6K	0.02%	184

Other funds holding TRAW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SFI

Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BPA

Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return

MONECO Advisors's TRAW Position: Q2 2021 in Review

MONECO Advisors sold out of Traws Pharma (TRAW) in Q2 2021, closing a stake of 80 shares — an estimated $30K sold.

MONECO Advisors first reported a position in TRAW in Q4 2020 and held it in 2 quarters. The position peaked at $41K in Q4 2020. 25 funds tracked by Wall St. Rank hold TRAW as of Q2 2021.

MONECO Advisors reported no remaining Traws Pharma position as of Q2 2021 after selling out during the quarter.
MONECO Advisors sold 80 Traws Pharma shares in Q2 2021, an estimated $30K.
MONECO Advisors first reported a position in Traws Pharma in Q4 2020 and held it in 2 quarters.
MONECO Advisors's Traws Pharma position peaked at $41K in Q4 2020.
25 funds tracked by Wall St. Rank held Traws Pharma as of Q2 2021.

Based on MONECO Advisors's 13F filing for Q2 2021, filed 10 Aug 2021.